NCT03719534View on ClinicalTrials.gov

Haplo HCT vs Haplo-cord HCT for Patients With AML

PHASE3CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

March 31, 2023

Conditions
Hematopoietic Stem Cell TransplantationHaplo-identical DonorCord Blood UnitAcute Myeloid Leukemia
Interventions
PROCEDURE

haplo-HCT

HCT will be performed with a haploidentical donor

PROCEDURE

haplo-cord HCT

Haploidentical donor HCT will be performed with coinfusion of unrelated cord blood unit

Trial Locations (5)

215006

The First Affiliated Hospital of Soochow University, Suzhou

215100

Soochow Hopes Hematology Hospital, Suzhou

215200

Hygeia Suzhou Yongding Hospital, Suzhou

223000

The Second People's Hospital of Huai'an, Huai'an

310003

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

Zhejiang University

OTHER

collaborator

The Second People's Hospital of Huai'an

OTHER

collaborator

Soochow Hopes Hematology Hospital

UNKNOWN

collaborator

Hygeia Suzhou Yongding Hospital

UNKNOWN

lead

The First Affiliated Hospital of Soochow University

OTHER

NCT03719534 - Haplo HCT vs Haplo-cord HCT for Patients With AML | Biotech Hunter | Biotech Hunter